Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02562794 · ClinicalTrials.gov registry record · NA

Addressing Mental Health Disparities in Refugee Children: A Community-based Participatory Research (CBPR) Collaboration

A NA study of Mental Disorders and Child/Adolescent Problems, sponsored by Boston College.

Completed
Registry status
NA
Development phase
265
Enrollment target
2
Study locations

NCT02562794: Completed NA study of Mental Disorders and Child/Adolescent Problems, sponsored by Boston College.

NCT02562794 is a NA study of Mental Disorders and Child/Adolescent Problems that has completed, run by Boston College. The registered enrollment target is 265 participants, below the 674-participant average among 25 other Mental Disorders trials with a reported enrollment target (61% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02562794, a NA study of Mental Disorders and Child/Adolescent Problems, has completed, sponsored by Boston College.

COMPLETED
Registry status
NA
Development phase
265 participants
Enrollment target
2
Study locations

Study Summary

This study will use CBPR mixed methods (qualitative and quantitative data collection) to conduct needs assessments and design and evaluate a core family-based intervention. Project activities will emphasize capacity building in two refugee communities resettled in Greater Boston-the Somali Bantu and the Bhutanese-actively engaging refugee community members, community advisory boards, services providers, and other stakeholders. Specific Aims are to: (1) deepen partnerships with the Somali Bantu and Bhutanese communities through co-leadership, capacity-building, and knowledge sharing; (2) collect and apply qualitative data to (a) prepare a needs assessment of mental health in children and adolescents, barriers to care, and services preferences with each target refugee group; (b) develop mental health/psychosocial assessments for refugee caregivers and children; (c) adapt the core components of a family-based strengthening intervention for use with refugees; and (3) conduct an 80-family pilot study to examine acceptability and sustainability of the intervention. Key outcomes will be reduced mental health symptoms among children and adolescents and improvement in caregiver-child relationships.

Primary Outcome

Depressive symptoms will be measured with an adapted version of the Center for Epidemiologic Study-Depression) CES-D scale

Interventions

  • BEHAVIORAL Family Strengthening Intervention-Refugees

Study Locations (2)

Massachusetts

  • Chelsea Collaborative - Chelsea
  • Jewish Family Service - Springfield

Trial Details

FieldValue
Enrollment Target 265 participants
Start Date 2016-08
Est. Completion 2019-04
Phase NA
Boston College

18 total trials

What the finished NCT02562794 record still lists

NCT02562794 is an interventional study that assigns participants to a tested intervention. The registered 265 participants enrollment target is mid-sized for trials with a published cap, below the 674-participant average among 25 other Mental Disorders trials with a reported enrollment target (61% lower).

The record links to 2 conditions, with Mental Disorders appearing as the primary indexed condition, and to 1 intervention - of which Family Strengthening Intervention-Refugees is the first listed.

NCT02562794 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02562794 about?

NCT02562794 is a clinical study titled "Addressing Mental Health Disparities in Refugee Children: A Community-based Participatory Research (CBPR) Collaboration". This study will use CBPR mixed methods (qualitative and quantitative data collection) to conduct needs assessments and design and evaluate a core family-based intervention. Project activities will emphasize capacity building in two refugee communities resettled in Greater Boston-the Somali Bantu and...

What is the current status of trial NCT02562794?

This trial is currently completed. It is a NA study. The enrollment target is 265 participants. The study started on 2016-08. Estimated completion is 2019-04.

What conditions does trial NCT02562794 study?

This clinical trial studies the following conditions: Mental Disorders, Child/Adolescent Problems.

What interventions are being tested in trial NCT02562794?

The interventions under investigation include: Family Strengthening Intervention-Refugees (BEHAVIORAL).

Who is sponsoring clinical trial NCT02562794?

This trial is sponsored by Boston College, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02562794 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02562794's enrollment target sits among peer trials

265 11th of 25 higher than 15 of 25 other Mental Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mental Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05443126 · 265 participants · Phase 1

    A Study of EP0031 in Patients With Advanced RET-altered Malignancies

  • NCT05470491 · 265 participants · Phase 1

    Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

  • NCT07301905 · 265 participants · NA

    Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI

  • NCT07470853 · 265 participants · Phase 1

    A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02562794, the US trial registry maintained by the National Library of Medicine. NCT02562794 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.